You are here

ocrelizumab

Roche Holding, Biogen to halt arthritis program

Marketwatch

Wed, 05/19/10 - 09:27 am

Roche arthritis drug meets goal, safety issues linger

Reuters

Tue, 04/20/10 - 10:47 am

Roche, Genentech and Biogen Idec announce positive results from first phase III trial of ocrelizumab

PR-Canada

Sun, 12/13/09 - 12:20 pm

Roche arthritis drug effective in late-stage study

Reuters

Fri, 12/11/09 - 10:33 am

Pages